Letter to the editors: Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful? [3]

British Journal of Clinical Pharmacology

Volumn 65, Issue 2, 2008, Pages 275-276

  Vroom, Fokaline ^a   Van Den Berg, Paul B ^a   De Jong Van Den Berg, Lolkje T W ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

CONGENITAL HEART MALFORMATION; GASTROSCHISIS; HUMAN; LETTER; NETHERLANDS; PRACTICE GUIDELINE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; ADOLESCENT; ADULT; CHEMICALLY INDUCED DISORDER; CONGENITAL DISORDER; FEMALE; MIDDLE AGED;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PRESCRIPTIONS, DRUG;

EID: 38649087028     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02994.x     Document Type: Letter

References (5)

1. Wording of the SPC of ASA and NSAIDs (April 2004). Accessed 14 2 2006, http://www.cbg-meb.nl/nl/docs/nieuws/art-asa-nsaid-spc-pregnancy.pdf.
2. Schirm E, Tobi H, de Jong-van den Berg LT. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol 2004 57 : 737 41.
3. Ofori B, Oraichi D, Blais L, Rey E, Berard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006 77 : 268 79.
4. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg Olsen J, Sorensen HT. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP Group. Eur J Clin Pharmacol 1999 55 : 139 44.
5. Ericson A, Kallen BA. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001 15 : 371 5.